Fundraising Fox

Eikonizo Therapeutics

Beverly, US · Founded 2017 · Delaware corporation · 1 known investors

eikonizo.com ↗

Eikonizo develops small molecule therapeutics targeting neurodegenerative and cardiorenal diseases. The company is focused on creating novel, disease-modifying treatments to improve patient outcomes.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devicesin /eikonizo-therapeutics@Eikonizo

Founders & leadership

WS
William ShawExecutive Officer, Director
KKKevin Kinsella
Kevin KinsellaDirector
SW
Stacie WeningerDirector
JK
Janice KranzExecutive Officer, Director

Investors · 1

Mission BiocapitalSan Francisco · $500K

Reported raises · per SEC filings

Form D private placements
▶$371.4KraisedMay 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Janice KranzExecutive Officer, Director
  • Stacie WeningerDirector
  • William ShawExecutive Officer, Director
  • Kevin KinsellaDirector
Offering amount
$841.1K
Amount sold
$371.4K
First sale
May 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedApr 2018 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William ShawExecutive Officer, Director
  • Kevin KinsellaDirector
  • Stacie WeningerDirector
  • Janice KranzExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news